MX2015006340A - Antibioticos macrociclicos de amplio espectro. - Google Patents
Antibioticos macrociclicos de amplio espectro.Info
- Publication number
- MX2015006340A MX2015006340A MX2015006340A MX2015006340A MX2015006340A MX 2015006340 A MX2015006340 A MX 2015006340A MX 2015006340 A MX2015006340 A MX 2015006340A MX 2015006340 A MX2015006340 A MX 2015006340A MX 2015006340 A MX2015006340 A MX 2015006340A
- Authority
- MX
- Mexico
- Prior art keywords
- broad spectrum
- compounds
- spectrum antibiotics
- macrocyclic
- macrocyclic broad
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a compuestos antibacterianos que en algunas formas de realización tienen un amplio espectro de bioactividad. En diversas formas de realización, los compuestos actúan por inhibición de la peptidasa de señal (SpsB) del tipo bacteriano 1, una proteína esencial de las bacterias. También se proveen composiciones farmacéuticas y métodos de tratamiento en los que se usan los compuestos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261729253P | 2012-11-21 | 2012-11-21 | |
US201261729249P | 2012-11-21 | 2012-11-21 | |
PCT/US2013/071093 WO2014081886A1 (en) | 2012-11-21 | 2013-11-20 | Macrocyclic broad spectrum antibiotics |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015006340A true MX2015006340A (es) | 2015-09-07 |
Family
ID=50728492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015006340A MX2015006340A (es) | 2012-11-21 | 2013-11-20 | Antibioticos macrociclicos de amplio espectro. |
Country Status (12)
Country | Link |
---|---|
US (1) | US9309285B2 (es) |
EP (1) | EP2922829B1 (es) |
JP (2) | JP6437443B2 (es) |
KR (1) | KR20150088292A (es) |
CN (1) | CN104903302B (es) |
AR (1) | AR093581A1 (es) |
BR (1) | BR112015011697A2 (es) |
CA (1) | CA2892027A1 (es) |
EA (1) | EA201590871A1 (es) |
MX (1) | MX2015006340A (es) |
TW (1) | TWI631127B (es) |
WO (1) | WO2014081886A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10501493B2 (en) | 2011-05-27 | 2019-12-10 | Rqx Pharmaceuticals, Inc. | Broad spectrum antibiotics |
EP2984166B1 (en) | 2013-03-15 | 2020-04-22 | The Trustees Of The University Of Pennsylvania | Compositions for treating mpsi |
BR112016027232A2 (pt) | 2014-05-20 | 2018-06-26 | Genentech Inc | antibióticos macrocíclicos de amplo espectro |
EP3289355A4 (en) * | 2015-04-30 | 2019-02-13 | IDEXX Laboratories, Inc. | METHODS OF DETECTING RENAL DISEASE |
MY193014A (en) | 2015-10-27 | 2022-09-22 | Hoffmann La Roche | Peptide macrocycles against acinetobacter baumannii |
TWI725075B (zh) * | 2015-11-20 | 2021-04-21 | 美商Rqx製藥公司 | 巨環廣效抗生素 |
KR20180109858A (ko) * | 2015-11-20 | 2018-10-08 | 알큐엑스 파마슈티컬스, 인크. | 마크로시클릭 광범위 항생제 |
UA126027C2 (uk) * | 2017-02-15 | 2022-08-03 | АрКьюЕкс ФАРМАСЬЮТІКЛС, ІНК. | Макроциклічні антибіотики широкого спектра |
EP3388444A1 (en) | 2017-04-10 | 2018-10-17 | F. Hoffmann-La Roche AG | Anti-bacterial peptide macrocycles and use thereof |
US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
RS64852B1 (sr) * | 2019-05-28 | 2023-12-29 | Hoffmann La Roche | Makrociklični antibiotici širokog spektra |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204328A (en) | 1990-06-26 | 1993-04-20 | Merck & Co., Inc. | Peptides having atrial natriuretic factor activity |
EP0895999A1 (en) * | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
US6660832B1 (en) * | 1999-08-20 | 2003-12-09 | Isis Pharmaceuticals, Inc. | Macrocyclic compounds and preparation methods thereof |
US6951840B2 (en) * | 2001-08-31 | 2005-10-04 | Eli Lilly And Company | Lipoglycopeptide antibiotics |
DE10226921A1 (de) * | 2002-06-17 | 2003-12-24 | Bayer Ag | Antibakterielle Amid-Makrozyklen |
AU2004252174A1 (en) | 2003-06-26 | 2005-01-06 | Migenix Inc. | Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
DE10358824A1 (de) * | 2003-12-16 | 2005-07-21 | Bayer Healthcare Ag | Antibakterielle Makrozyklen mit substituiertem Biphenyl |
DE102005014245A1 (de) | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen V |
DE102005014247A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen VI |
CA2791732A1 (en) * | 2010-03-09 | 2011-09-15 | Scott K. Smith | Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials |
AU2010350241A1 (en) | 2010-04-01 | 2012-10-25 | The University Of Queensland | Oxytocin peptide analogues |
WO2012036907A2 (en) * | 2010-09-15 | 2012-03-22 | Romesberg Floyd E | Broad spectrum antibiotic arylomycin analogs |
WO2012166665A2 (en) | 2011-05-27 | 2012-12-06 | Rqx Pharmaceuticals, Inc. | Broad spectrum antibiotics |
EA201491646A1 (ru) | 2012-03-14 | 2015-03-31 | Дзе Скриппс Рисёч Инститьют | Аналоги антибиотика ариломицина широкого действия |
-
2013
- 2013-11-20 KR KR1020157016534A patent/KR20150088292A/ko unknown
- 2013-11-20 EP EP13856377.0A patent/EP2922829B1/en active Active
- 2013-11-20 MX MX2015006340A patent/MX2015006340A/es unknown
- 2013-11-20 EA EA201590871A patent/EA201590871A1/ru unknown
- 2013-11-20 CA CA2892027A patent/CA2892027A1/en not_active Abandoned
- 2013-11-20 JP JP2015544117A patent/JP6437443B2/ja active Active
- 2013-11-20 CN CN201380069987.6A patent/CN104903302B/zh active Active
- 2013-11-20 BR BR112015011697A patent/BR112015011697A2/pt not_active Application Discontinuation
- 2013-11-20 WO PCT/US2013/071093 patent/WO2014081886A1/en active Application Filing
- 2013-11-21 TW TW102142527A patent/TWI631127B/zh not_active IP Right Cessation
- 2013-11-21 AR ARP130104303A patent/AR093581A1/es unknown
- 2013-11-21 US US14/086,908 patent/US9309285B2/en active Active
-
2018
- 2018-07-18 JP JP2018135357A patent/JP6662960B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
WO2014081886A1 (en) | 2014-05-30 |
CN104903302A (zh) | 2015-09-09 |
EP2922829B1 (en) | 2021-08-11 |
TW201434848A (zh) | 2014-09-16 |
JP2016501864A (ja) | 2016-01-21 |
EP2922829A4 (en) | 2016-11-02 |
JP6662960B2 (ja) | 2020-03-11 |
EP2922829A1 (en) | 2015-09-30 |
CN104903302B (zh) | 2019-03-29 |
CA2892027A1 (en) | 2014-05-30 |
US20140142029A1 (en) | 2014-05-22 |
JP6437443B2 (ja) | 2018-12-12 |
JP2018184435A (ja) | 2018-11-22 |
US9309285B2 (en) | 2016-04-12 |
KR20150088292A (ko) | 2015-07-31 |
BR112015011697A2 (pt) | 2017-07-11 |
TWI631127B (zh) | 2018-08-01 |
EA201590871A1 (ru) | 2015-11-30 |
AR093581A1 (es) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016015218A (es) | Antibioticos macrociclicos de amplio espectro. | |
MX2015006340A (es) | Antibioticos macrociclicos de amplio espectro. | |
MX2018006190A (es) | Antibioticos de amplio espectro macrociclico. | |
AU2015205914B2 (en) | 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections | |
MX2018006199A (es) | Antibioticos de amplio espectro macrociclico. | |
MX2015007556A (es) | Derivados de manosa para tratar infecciones bacterianas. | |
PH12019501904A1 (en) | Macrocyclic broad spectrum antibiotics | |
MX340533B (es) | Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas. | |
EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
WO2013122888A3 (en) | Methods of treating bacterial infections | |
MX349827B (es) | Compuestos que contienen nitrogeno y su uso. | |
NZ618571A (en) | Peptides and their use | |
TW200734344A (en) | Antibacterial agents | |
CR20210682A (es) | Antibióticos macrocíclicos de amplio espectro | |
MX2014009899A (es) | Antibioticos peptidicos lineales. | |
WO2012166665A3 (en) | Broad spectrum antibiotics | |
WO2014022382A3 (en) | Antibacterial protein kinase inhibitors | |
WO2013083975A3 (en) | Novel pyrrole derivatives | |
WO2017218922A3 (en) | Compositions and methods for the treatment of bacterial infections | |
MX2016001927A (es) | Antibióticos de péptidos lineales. | |
PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
WO2019067498A3 (en) | Peptide antibiotic complexes and methods of use thereof | |
PH12015500518A1 (en) | Tricyclic tetrahydroquinoline antibacterial agents | |
WO2008142102A3 (en) | Use of transferrin for preparing pharmaceutical compositions useful for treating bacterial infections as coadjuvants in antibiotic therapy | |
MX360040B (es) | Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno. |